Screener
Aclaris Therapeutics ACRS Free cash flow
Free cash flow at other companies
Other financials
Where this comes from
Calculated from Aclaris Therapeutics’s reported figures.
The source filing: Aclaris Therapeutics’s 10-Q, filed August 6, 2026. Open the filing →
- Filed
- Aug 6, 2026, 4:31 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001104659-26-092065
FAQ
- What is Aclaris Therapeutics's free cash flow?
- Aclaris Therapeutics (ACRS) reported free cash flow of -$19.91M in Q2 2026.
- How has Aclaris Therapeutics's free cash flow changed year-over-year?
- Aclaris Therapeutics's free cash flow decreased by 98.8% year-over-year, from -$10.01M to -$19.91M.
- What is the long-term trend for Aclaris Therapeutics's free cash flow?
- Over 2 years (2022 to 2025), Aclaris Therapeutics's free cash flow has grown at a -16.8% compound annual growth rate (CAGR), from -$68.17M to -$47.22M.
- What does free cash flow mean?
- Free cash flow represents the cash generated by a company after accounting for cash outflows to support operations and maintain or expand its capital asset base. It serves as a critical indicator of a company's ability to fund organic growth, pay down debt, or return capital to shareholders without relying on external financing.
Ask your AI about Aclaris Therapeutics's free cash flow.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude